Meet interventional cardiologist and guidelines author Professor Rob Storey and learn his views on the best regimen of antithrombotic therapy for AF patients with ACS and/or PCI in these video interviews.
Professor Storey introduces himself and details his research interests and guideline involvement.
Learn about the challenge of treating patients with atrial fibrillation who have presentation with acute coronary syndrome and or need percutaneous coronary intervention.
Professor Storey gives his view on how to individualise therapy most effectively.
Find out about the more recent studies looking at the critical endpoints of stroke and stent thrombosis prevention in this patient population.
Find out if a direct oral anticoagulant (DOAC) is better than a vitamin K antagonist in trying to balance efficacy and safety in these patients.
Find out when it is safe to drop aspirin.
Learn about the importance of the 2x2 factorial design of the AUGUSTUS trial.
Find out why we still need to identify patients that require more intensive therapy.
Is triple therapy on the way out?
Find out Professor Storey’s concerns on the robustness of real-world evidence.
Surely clinical trials are also carried out in the real world?
Find out how the ESC guidelines on chronic coronary syndromes have taken onboard the evidence from AUGUSTUS and more recent studies.
Back to Expert Opinion
Alternatively login via
Back to epgonline.org